Device Trial Radar · NCT00948025
A Comparative Post-marketing Study of Commercially Available Peripheral Nerve Gap Repair Options
Last checked: Nov 20, 2026Latest source record: Dec 1, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
23
Actual
Start
Jun 2009
Primary completion
Dec 2014
Study completion Dec 2014
Sponsor
- Lead sponsor
- Axogen CorporationNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 29, 2009
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a comparison of sensory recovery outcomes following the use of AVANCE Nerve Graft or hollow tube conduit for peripheral nerve gap repairs in the hand.
Conditions
- Traumatic Nerve Injury
Interventions
Hollow tube nerve conduit, synthetic or biosyntheticDevice
Appropriately size matched hollow tube nerve conduit (Neurotube, NeuroLac, NeuraGen, NeuroMatrix, NeuroFlex)
Processed Human Nerve TissueOther
Implantation of appropriate length of processed human nerve tissue at time of surgery.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Recovery of Static 2-point Discrimination in the Affected DigitTime frame: 12 Months
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Georgia Hand, Shoulder and Elbow
Atlanta, Georgia
Indiana Hand Center
Indianapolis, Indiana
University of Kentucky
Lexington, Kentucky
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.